Photo of Gus M. Bilirakis
R United States House · District 12 · Florida On the 2026 ballot

Rep. Gus M. Bilirakis

Compare
Total votes
2,818
all sessions
Attendance
97%
78 missed
Near the chamber average
With party
96%
of cast votes
Higher than 80% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Lower than 80% of chamber peers
Sponsored
1,245
bills & resolutions
Near the chamber average
Committees
4
assignments
1,245 bills and resolutions

Sponsored bills

Total
1,245
Primary
97
Co-sponsor
1,148
This page
1,245
matching current filters
Co-sponsor HR 3447
In committee · Delaware House · Co-sponsor
Chip Security Act

Maddy summaryHR 3447, the Chip Security Act, requires manufacturers to equip specific advanced integrated circuits (classified under export control numbers like 3A090) with security mechanisms before exporting them. These mechanisms must verify location and prevent unauthorized access, diversion, or tampering. The law mandates this for covered chips within 180 days of enactment, with a follow-up assessment within one year to develop additional security requirements. It directly affects U.S. chip exporters and importers of these high-tech products, aiming to strengthen export control compliance and national security.

In committee Mar 26, 2026 1 co-sponsor
Co-sponsor HR 5663
Passed · Delaware House · Co-sponsor
ACPAC Modernization Act

Maddy summaryHR 5663, the ACPAC Modernization Act, amends the FAA Modernization and Reform Act of 2012 to add "ticket agents" as a required member category on the Aviation Consumer Protection Advisory Committee (ACPAC). This change directly affects ACPAC's composition by mandating that ticket agents be included among its members. The bill makes a technical, procedural update to the existing law without altering the committee's functions or creating new consumer protections. It focuses solely on specifying who must serve on the committee, not on changing airline consumer policies.

Passed Mar 25, 2026 1 co-sponsor
Primary HR 8000
In committee · Delaware House · Lead sponsor
END 7-OH Act

Maddy summaryThis bill proposes to add 7-hydroxymitragynine to Schedule I of the Controlled Substances Act, classifying it as a controlled substance. The legislation specifically excludes naturally occurring 7-hydroxymitragynine found in kratom plants from this classification while including synthetic versions. This change would require federal regulation of synthetic forms of the compound but would not affect kratom products containing the substance in its natural state. The bill directly impacts pharmaceutical manufacturers and synthetic drug producers who would need to comply with new federal scheduling requirements.

In committee Mar 19, 2026 0 co-sponsors
Co-sponsor HR 1799
In committee · Delaware House · Co-sponsor
Financial Reporting Threshold Modernization Act

Maddy summaryHR 1799, the Financial Reporting Threshold Modernization Act, raises reporting thresholds for financial institutions handling large cash transactions. It increases the threshold for currency transaction reports from $10,000 to $30,000 and adjusts suspicious activity report thresholds from $5,000/$2,000 to $10,000/$3,000. The bill requires automatic updates to these thresholds every five years using the Consumer Price Index to account for inflation. This directly affects banks, money services businesses, and other entities that must file these reports under U.S. financial regulations.

In committee Mar 19, 2026 1 co-sponsor
Co-sponsor HR 1422
Passed · Delaware House · Co-sponsor
Enhanced Iran Sanctions Act of 2025

Enhanced Iran Sanctions Act of 2025 This bill imposes sanctions on certain foreign persons (individuals and entities) that are involved in Iran's petroleum sector as well as certain associated persons. The bill also requires or authorizes actions to facilitate the enforcement of sanctions on Iran. Specifically, the bill requires the President to impose visa- and property-blocking sanctions on any foreign person that, after the bill's enactment, knowingly engages in any transaction related to the processing, export, or sale of oil, condensates, gas, liquefied natural gas, or other petrochemical products in whole or in part from Iran. The President must also impose sanctions on certain foreign persons associated with a sanctioned individual or entity. For example, the President must sanction the subsidiaries and corporate officers of a sanctioned business. The bill provides certain exceptions to these sanctions, including specifying that sanctions do not apply to the importation of goods or to conducting or facilitating transactions for humanitarian assistance. The Department of State must establish an interagency working group that shall seek to establish a multilateral contact group to coordinate international efforts to enforce sanctions on Iran. The bill expands the State Department rewards program to authorize a reward payment to any individual who furnishes information leading to the identification of a person (1) subject to sanctions under this bill, or (2) that has attempted or is attempting to evade sanctions under this bill.

Passed Mar 17, 2026 1 co-sponsor
Co-sponsor HR 7905
In committee · Delaware House · Co-sponsor
Diabetes Foot Health Access and Modernization Act of 2026

Maddy summaryThis bill, known as the Diabetes Foot Health Access and Modernization Act of 2026, makes two main changes to federal healthcare programs. First, it allows Medicaid to cover foot and ankle care services provided by podiatric physicians, ensuring patients have access to this specialized care. Second, it updates Medicare rules to clarify documentation requirements for diabetic shoes, specifying conditions under which patients can receive extra-depth or custom-molded footwear. The changes take effect on January 1, 2026, for Medicaid services and January 1, 2028, for Medicare shoe coverage.

In committee Mar 12, 2026 1 co-sponsor
Co-sponsor HR 7871
In committee · Delaware House · Co-sponsor
MVP Act

Maddy summaryHR 7871 (MVP Act) updates Medicaid drug rebate rules to allow manufacturers to report multiple "best price points" for drugs sold under outcome-based payment arrangements, requiring these arrangements to be offered to all states. It clarifies how average manufacturer price is calculated for such drugs and exempts certain outcome-linked payments from anti-kickback laws. The bill also mandates a GAO study to assess whether these arrangements improve patient access, lower costs, and reduce disparities in drug coverage. This affects Medicaid programs nationwide, drug manufacturers, and patients receiving covered outpatient drugs under Medicaid.

In committee Mar 9, 2026 1 co-sponsor
Primary HR 7863
In committee · Delaware House · Lead sponsor
Promoting Fairness for Medicare Providers Act of 2026

Maddy summaryThis bill, titled the Promoting Fairness for Medicare Providers Act of 2026, changes how Medicare pays for certain surgical procedures performed in doctors' offices when those procedures involve expensive medical supplies. Starting in 2027, Medicare will pay office-based facilities 80% of the amount it would pay for the same procedures performed in ambulatory surgical centers, with additional rules for device-intensive procedures. The bill defines which procedures qualify based on supply costs exceeding $500 and requires participating doctors' offices to agree to accept these payment amounts as full payment. The list of covered procedures will be reviewed annually beginning in 2028, with the Secretary of Health and Human Services able to add or remove procedures based on supply cost thresholds that adjust for inflation.

In committee Mar 9, 2026 0 co-sponsors
Co-sponsor HR 7815
In committee · Delaware House · Co-sponsor
Red Star Service Banner Act

Maddy summaryThis bill establishes the Red Star Service Banner as an officially recognized symbol to honor U.S. service members and veterans who died by suicide, as well as first responders who died by suicide. The banner features a white field with a blue border and a single red star, and it may be displayed at private residences, workplaces, public buildings, community spaces, and other appropriate locations to recognize the sacrifice of those who died and support their families. The legislation clarifies that displaying the banner does not create new eligibility for benefits, requires VA approval for individual display, or establish any legal status beyond recognition. It also allows the Secretary of Veterans Affairs to promote awareness of the banner in coordination with the Department of Defense without requiring additional funding.

In committee Mar 5, 2026 1 co-sponsor
Co-sponsor HR 7779
In committee · Delaware House · Co-sponsor
HEALTHY BRAINS Act of 2026

Maddy summaryThis bill directs the Secretary of Health and Human Services to create a program focused on researching how environmental factors, such as air pollution, chemicals, and heavy metals, may contribute to neurodegenerative diseases like Alzheimer's and Parkinson's. The legislation would establish collaborative research centers at universities and medical institutions to study these environmental links, train scientists, and share findings with the public and healthcare professionals. The program includes provisions for creating a national data system and information clearinghouse to track disease patterns and environmental exposures across different communities. Funding of up to $50 million annually through 2031 is authorized to support these research efforts, with biennial reports required to Congress on progress and outcomes.

In committee Mar 3, 2026 1 co-sponsor
Showing 81 to 90 of 1,245 bills
Previous 1 8 9 10 125 Next